AB Cube Germany and BSI Life Sciences Announce Integration Partnership
Marvin EDC and BSI Life Sciences’ CTMS and eTMF now offer study teams a seamlessly connected eClinical platform
(PresseBox) - AB Cube Germany GmbH, developer of Marvin EDC, and BSI Life Sciences, an industry leader in CTMS and eTMF software, announced a strategic integration partnership that brings together their complementary eClinical technologies to support modern clinical development.
The partnership enables seamless data exchange between BSI Life Sciences’ clinical operations platform covering Clinical Trial Management (CTMS), electronic Trial Master File (eTMF) and Marvin EDC, AB Cube’s secure, cloud-based Electronic Data Capture solution. Sponsors and CROs now benefit from a fully connected, compliant environment without sacrificing flexibility or their choice of best-of-breed tools.
A Shared Commitment to Interoperability
“With Marvin connected to BSI Life Sciences’ CTMS and eTMF, we are bringing together complementary technologies for modern clinical development. This partnership supports a best-of-breed strategy while giving sponsors and CROs a connected, compliant platform across clinical data, operations, pharmacovigilance, and trial documentation.”
— Manuel Neukum, CEO, AB Cube Germany GmbH
“Marvin and BSI Life Sciences’ eClinical solutions are built on the same commitment to interoperability, open standards, and strong usability. For clinical leaders, that means less integration effort, less duplicate entry, and a more reliable flow of information from data capture through to operational management and TMF documentation.”
— Philip Skou, Managing Director, BSI Life Sciences
What the Integration Delivers:
The integration addresses a growing demand from study teams for interoperable solutions that reduce manual data reconciliation and simplify cross-system workflows. Key benefits include:
Automated data exchange between Marvin EDC and BSI CTMS, eliminating duplicate data entry
Streamlined TMF documentation via direct connectivity with BSI’s eTMF module
A unified view of clinical operations, from data capture to site management and trial documentation
Maintained compliance with 21 CFR Part 11, ICH-GCP, and CDISC ODM standards across both platforms
Flexibility for sponsors and CROs to adopt a best-of-breed approach without integration overhead
To learn more about the partnership or to book a demo, visit www.marvin.now or www.bsi-lifesciences.com.
AB-Cube Germany GmbH, (formerly XClinical), is a leading European provider of eClinical technologies and the developer of the platforms Marvin EDC and asthenis.
Marvin offers an integrated suite of clinical modules, including EDC, IWRS/RTSM, Medical Coding, ePRO, and advanced reporting tools, designed to support complex and oncology-focused clinical trials.
asthenis is an oncology-focused documentation, registry, and tumour board solution used primarily by hospitals and academic institutions. It captures real-world cancer patient data from routine clinical practice and supports registries and outcomes research.
About BSI Life Sciences
BSI Life Sciences, part of BSI Business Systems Integration AG, is an industry-leading provider of CTMS and eTMF solutions for clinical trials. Headquartered in Baden, Switzerland, BSI Life Sciences serves sponsors and CROs globally with an integrated eClinical platform covering CTMS, eTMF, Study Startup, Trial Supply Management (TSM), and Learning Management (LMS). BSI’s modern platform is built for ease of use, compliance, and interoperability
Unternehmensinformation / Kurzprofil:
AB-Cube Germany GmbH, (formerly XClinical), is a leading European provider of eClinical technologies and the developer of the platforms Marvin EDC and asthenis.
Marvin offers an integrated suite of clinical modules, including EDC, IWRS/RTSM, Medical Coding, ePRO, and advanced reporting tools, designed to support complex and oncology-focused clinical trials.
asthenis is an oncology-focused documentation, registry, and tumour board solution used primarily by hospitals and academic institutions. It captures real-world cancer patient data from routine clinical practice and supports registries and outcomes research.
About BSI Life Sciences
BSI Life Sciences, part of BSI Business Systems Integration AG, is an industry-leading provider of CTMS and eTMF solutions for clinical trials. Headquartered in Baden, Switzerland, BSI Life Sciences serves sponsors and CROs globally with an integrated eClinical platform covering CTMS, eTMF, Study Startup, Trial Supply Management (TSM), and Learning Management (LMS). BSI’s modern platform is built for ease of use, compliance, and interoperability
Datum: 05.05.2026 - 11:08 Uhr
Sprache: Deutsch
News-ID 736104
Anzahl Zeichen: 3851
contact information:
Contact person: Sabine Birkner
Town:
München
Phone: 0894522775000
Kategorie:
Manufacturing & Production
Diese Pressemitteilung wurde bisher 129 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"AB Cube Germany and BSI Life Sciences Announce Integration Partnership"
steht unter der journalistisch-redaktionellen Verantwortung von
AB Cube Germany GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
